Plus Therapeutics, Inc.
PSTV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$12,978 | -$13,316 | -$20,275 | -$13,399 |
| Dep. & Amort. | $723 | $628 | $619 | $395 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $550 | $569 | $606 | $606 |
| Change in WC | $3,222 | -$1,116 | $5,597 | $1,238 |
| Other Non-Cash | -$2,071 | $384 | $481 | $880 |
| Operating Cash Flow | -$10,554 | -$12,851 | -$12,972 | -$10,280 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$146 | -$160 | -$509 | -$144 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$15,590 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $12,170 | $0 | $0 | $0 |
| Other Inv. Act. | -$545 | $0 | -$250 | $62 |
| Investing Cash Flow | -$4,111 | -$160 | -$759 | -$82 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$704 | -$1,608 | -$1,608 | -$276 |
| Stock Issued | $7,265 | $5,527 | $15,832 | $18,675 |
| Stock Repurch. | -$374 | -$126 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$348 | -$773 | $2,017 |
| Financing Cash Flow | $6,187 | $3,445 | $13,451 | $20,416 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$8,478 | -$9,566 | -$280 | $10,054 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,554 | $18,120 | $18,400 | $8,346 |
| End Cash | $76 | $8,554 | $18,120 | $18,400 |
| Free Cash Flow | -$10,700 | -$13,011 | -$13,731 | -$10,424 |